Rett Syndrome Awareness Month

October is Rett Syndrome Awareness Month. Rett Syndrome is a genetic disease which affects brain development. It is caused by identifiable mutations of the MECP2 gene on the X chromosome.

This life-threating condition affects about 1 in 10,000 girls and even fewer boys.

The most common symptoms of Rett Syndrome are the limited ability to play, the complexity of participation in normal activities and even the use of their voice. Rett Syndrome can shorten the lifespan of patients.

Nevertheless, the outcome of the condition depends on the age of the individual, and when the symptoms first occurred. There is still no cure for Rett Syndrome, and all available drugs aim to only treat the symptoms.

GCT focuses on Neurologic and CNS studies and has more than 19 years of experience conducting research in various indications. Contact us at to receive more information about our experience and capabilities. 

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.